Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tPA for aneurysmal subarachnoid hemorrhage
NCT01098890Phase 2Unknown
- Sponsor
- University of Calgary
- Start
- Oct 2009
- Primary completion
- Oct 2011
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of tissue-plasminogen activator in aneurysmal subarachnoid hemorrhage (SAH), Intraventricular hemorrhage (IVH), sponsored by University of Calgary. Status: unknown.
02
Drugs
tissue-plasminogen activator
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)Intraventricular hemorrhage (IVH)
Beyond the preview
Go deeper on NCT01098890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01098890.